Trial Results Search
Clinical Trial Results: Herceptin [trastuzumab]
-
Protocol Number: MO16982
Product Name: Herceptin [trastuzumab]
Date of Report: 01.04.2008
Phase: IV
-
Protocol Number: ML17263
Product Name: Herceptin [trastuzumab]
Date of Report: 03.07.2008
Phase: II
-
Protocol Number: BO16348
Product Name: Herceptin [trastuzumab]
Date of Report: 01.01.2006
Phase: III
-
Protocol Number: MO16419
Product Name: Herceptin [trastuzumab]
Date of Report: 01.04.2008
Phase: II
-
Protocol Number: M77003
Product Name: Herceptin [trastuzumab]
Date of Report: 03.11.2008
Phase: II
-
Protocol Number: WO16229
Product Name: Herceptin [trastuzumab]
Date of Report: 01.01.2004
Phase: II
-
Protocol Number: M77001
Product Name: Herceptin [trastuzumab]
Date of Report: 15.09.2003
Phase: II
-
Protocol Number: M77050
Product Name: Herceptin [trastuzumab]
Date of Report: 03.07.2006
Phase: II
-
Protocol Number: BO16216
Product Name: Herceptin [trastuzumab]
Date of Report: 01.08.2006
Phase: III
-
Protocol Number: MO28048
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: III
-
Protocol Number: BO25532
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: I
-
Protocol Number: BO20652
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: IV
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
-
Protocol Number: ML25288
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22056
Product Name: HERCEPTIN [trastuzumab]
Date of Report: To be Published
Phase: II
-
Protocol Number: ML25477
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML21833
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: II
-
Protocol Number: ML28589
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: III
-
Protocol Number: ML25574
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: II
-
Protocol Number: ML17743
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: II
-
Protocol Number: MO22982
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: II
-
Protocol Number: H4613g
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: I
-
Protocol Number: ML22834
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML23001
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25235
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: IV
-
Protocol Number: M77024
Product Name: Herceptin [trastuzumab]
Date of Report: 03.10.2005
Phase: II
-
Protocol Number: M77502
Product Name: Herceptin [trastuzumab]
Date of Report: 15.03.2006
Phase: II
-
Protocol Number: ML28934
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: IV
-
Protocol Number: M77998
Product Name: Herceptin [trastuzumab]
Date of Report: 11.10.2002
Phase: IV
-
Protocol Number: BO27798
Product Name: Herceptin [trastuzumab]
Date of Report: To be Published
Phase: III
-
Protocol Number: M77004
Product Name: Herceptin [trastuzumab]
Date of Report: 01.09.2004
Phase: II
-
Protocol Number: M77022
Product Name: Herceptin [trastuzumab]
Date of Report: 11.03.2004
Phase: II
About This Database
This database is populated with information on the results of Roche-sponsored clinical trials.